In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes . The Review of Diabetic Studies , [S. l.], v. 9, n. 4, 2023. Disponível em: https://diabeticstudies.org/index.php/RDS/article/view/184. Acesso em: 13 sep. 2025.